CN105311179A - Formulation for treating Bi-syndrome pain in upper extremities - Google Patents

Formulation for treating Bi-syndrome pain in upper extremities Download PDF

Info

Publication number
CN105311179A
CN105311179A CN201410368950.XA CN201410368950A CN105311179A CN 105311179 A CN105311179 A CN 105311179A CN 201410368950 A CN201410368950 A CN 201410368950A CN 105311179 A CN105311179 A CN 105311179A
Authority
CN
China
Prior art keywords
grams
formula
radix
upper limb
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410368950.XA
Other languages
Chinese (zh)
Inventor
高晓燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410368950.XA priority Critical patent/CN105311179A/en
Publication of CN105311179A publication Critical patent/CN105311179A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a formulation for treating Bi-syndrome pain in upper extremities, comprising components by weight: Radix Astragali 40 g, Herba Taxilli 40 g, Rhizoma Atractylodis 40 g, Rhizoma Chuanxiong 10 g, Radix Paeoniae Alba 20 g, Radix Angelicae Sinensis, Radix Gentianae Macrophyllae 25 g, Retinervus Citri Reticulatae 25 g. The formulation is applicable to patients of different ages suffering the Bi-syndrome pain in upper extremities, the pain borne by the patients is all caused by qi and blood obstruction that is caused by four factors, wind, cold, damp and stasis, and the formulation gives qi and blood circulation smoothness for the patients to finally eliminate the symptom by using three treatment principles, activating blood to remove stasis, removing wind to remove damp and promoting qi circulation to relieve pain.

Description

Control the formula of upper limb paralysis pain
Technical field
The present invention relates to a kind of Chinese medicine formula, be specifically related to the formula controlling upper limb paralysis pain.
Background technology
Upper limb paralysis refer to human upper limb meridians because of experience that wind, cold, wet, heat etc. causes with limbs joint and muscular soreness, numbness, weigh, joint stuffiness, even the scorching hot grade of arthroncus is a class disease of primary symptom, there is feature that is gradual or repeated relapsing clinically, mainly obstructed, the muscle arteries and veins joint of QI and blood numbness resistance is lost caused by moisten and support, during morbidity, limbs joint, muscle muscles and bones there will be lasting severe pain sense, obtain warm rear alleviation of pain, meet cold rear pain increasing.The words curative effect using cupping to treat this disease also varies with each individual, and some patient is after the treatment of use cupping or unsatisfactory curative effect.The invention discloses the formula controlling upper limb paralysis pain, this formula adopts this three large treatment principle of blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness, promoting the circulation of QI to relieve pain to make the normal circulation of qi and blood of patient, and disease is progressively dispelled the most at last.
Summary of the invention
The invention provides the formula controlling upper limb paralysis pain, the present invention is achieved by the following technical solutions.
Control the formula of upper limb paralysis pain, described recipe ingredient and separately weight are: the Radix Astragali 40 grams, Herba Taxilli 40 grams, Rhizoma Atractylodis 40 grams, Rhizoma Chuanxiong 10 grams, the Radix Paeoniae Alba 20 grams, Radix Angelicae Sinensis 20 grams, Radix Gentianae Macrophyllae 25 grams, Vascular aurantii 25 grams.
Each component in this formula is the dose of 1 dose, and notably, Radix Astragali consumption must add to 80 grams to the deficiency of vital energy, and adds Radix Ginseng Rubra 5 grams, does not decoct and takes after mixing it with water, and every day 1 dose 15 days is a course for the treatment of.
Beneficial effect of the present invention is: the formula controlling upper limb paralysis pain of the present invention is applicable to the patient tormented by upper limb paralysis pain of Different age group, the pain of patient be QI and blood not smooth caused by, not smooth is because wind, cold, wet, the stasis of blood four reasons cause, this formula adopts this three large treatment principle of blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness, promoting the circulation of QI to relieve pain to make the normal circulation of qi and blood of patient, and disease is progressively dispelled the most at last.
Detailed description of the invention
Control the formula of upper limb paralysis pain, component and separately weight portion are: the Radix Astragali 40 grams, Herba Taxilli 40 grams, Rhizoma Atractylodis 40 grams, Rhizoma Chuanxiong 10 grams, the Radix Paeoniae Alba 20 grams, Radix Angelicae Sinensis 20 grams, Radix Gentianae Macrophyllae 25 grams, Vascular aurantii 25 grams.
Each component in this formula is the dose of 1 dose, and notably, Radix Astragali consumption must add to 80 grams to the deficiency of vital energy, and adds Radix Ginseng Rubra 5 grams, does not decoct and takes after mixing it with water, and every day 1 dose 15 days is a course for the treatment of.

Claims (4)

1. control the formula of upper limb paralysis pain, it is characterized in that described recipe ingredient and respective weight are: the Radix Astragali 40 grams, Herba Taxilli 40 grams, Rhizoma Atractylodis 40 grams, Rhizoma Chuanxiong 10 grams, the Radix Paeoniae Alba 20 grams, Radix Angelicae Sinensis 20 grams, Radix Gentianae Macrophyllae 25 grams, Vascular aurantii 25 grams.
2. the formula controlling upper limb paralysis pain according to claim 1, each component that it is characterized in that in this formula is the dose of 1 dose, and notably, Radix Astragali consumption must add to 80 grams to the deficiency of vital energy, and adds Radix Ginseng Rubra 5 grams, does not decoct and takes after mixing it with water, every day 1 dose, within 15 days, is a course for the treatment of.
3. the formula controlling upper limb paralysis pain according to claim 1, it is characterized in that the Rhizoma Atractylodis in this formula have effect that is drying damp and strengthening spleen, expelling wind and cold, for rheumatic arthralgia, distension and fullness in the abdomen, edema of having loose bowels, beriberi flaccidity of feet with lamenness, so Rhizoma Atractylodis are the important simply medical materials in this formula.
4. the formula controlling upper limb paralysis pain according to claim 2, is characterized in that will must guard against edible Fructus Capsici during taking this formula, Pericarpium Zanthoxyli, Fructus Piperis, Cortex Cinnamomi, Rhizoma Zingiberis Recens, Bulbus Allii Fistulosi, Chinese liquor Isothermal Hot helps fiery food, otherwise can have a strong impact on curative effect.
CN201410368950.XA 2014-07-30 2014-07-30 Formulation for treating Bi-syndrome pain in upper extremities Pending CN105311179A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410368950.XA CN105311179A (en) 2014-07-30 2014-07-30 Formulation for treating Bi-syndrome pain in upper extremities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410368950.XA CN105311179A (en) 2014-07-30 2014-07-30 Formulation for treating Bi-syndrome pain in upper extremities

Publications (1)

Publication Number Publication Date
CN105311179A true CN105311179A (en) 2016-02-10

Family

ID=55240136

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410368950.XA Pending CN105311179A (en) 2014-07-30 2014-07-30 Formulation for treating Bi-syndrome pain in upper extremities

Country Status (1)

Country Link
CN (1) CN105311179A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254292A (en) * 2008-03-26 2008-09-03 张劼 Medicament for curing neck and upper limb paralysis
CN102008551A (en) * 2010-11-30 2011-04-13 潘畅 Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254292A (en) * 2008-03-26 2008-09-03 张劼 Medicament for curing neck and upper limb paralysis
CN102008551A (en) * 2010-11-30 2011-04-13 潘畅 Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
林德树: "治上肢痹症疼痛方处方与用法", 《HTTP://BLOG.SINA.COM.CN/S/BLOG_4EEFCF5001007V9L.HTML》 *

Similar Documents

Publication Publication Date Title
CN105125797A (en) External fumigation medicinal liquor for treating rheumatic arthromyodynia as well as cervical spondylopathy and lumbar spondylosis
CN102698231A (en) Tablets for tonifying qi and warming channels to relieve rheumatism
CN103251914A (en) Medicament for treating rheumatoid bone diseases
CN104027532A (en) Traditional Chinese medicine fomentation paste for treating rheumatism
CN103041261A (en) Traditional Chinese medicine composition for treating heat type arthritis
CN102357173A (en) Traditional Chinese medicine formula for curing rheumatism
CN104958699A (en) Traditional Chinese medicine composition for treating arthralgia
CN104288274A (en) Traditional Chinese medicine composition for treating rheumatoid spinal bone diseases
CN103330798A (en) Traditional Chinese medicinal preparation for treating rheumatisms
CN102048965A (en) Medicinal knee belt for treating rheumatalgia
CN103191229B (en) Traditional Chinese medicine for treating swelling of knee joints
CN102784212B (en) Chinese medicine composition for treating arthralgia-synadrome
CN105311179A (en) Formulation for treating Bi-syndrome pain in upper extremities
CN102949508A (en) Group of hot ironing muscle relaxing powder
CN102008600A (en) Steam bath health-preserving fumigation powder
CN104027451B (en) A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica
CN103127349B (en) Medicine for treating traumatic injury
CN107737248A (en) One kind is activated blood and relaxed tendons lavipeditum powder and preparation method thereof
CN102961527B (en) Traditional Chinese medicine for treating lumbar disc herniation
CN106581574A (en) Exercise soft tissue injury treating traditional Chinese medicine and preparation method thereof
CN106166181A (en) The local topical Traditional Chinese medicinal liquor for the treatment of arthralgia due to wind-cold-dampness disease
CN105055789A (en) Traditional Chinese medicine fumigant for relieving pain of soft tissue injury and preparation method thereof
CN106581514A (en) Traditional Chinese medicine for treating rheumatic arthralgia
CN103768463B (en) A kind of Chinese medicine decoction for the treatment of arthromyodynia
CN102526292A (en) Chinese medicinal composition for treating lumbar muscle degeneration

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160210

WD01 Invention patent application deemed withdrawn after publication